About this trial
This is a Registry that invites patients undergoing colorectal surgery for colorectal cancer. Epidemiological data is collected. The Registry includes tumor tissue and blood banks for analyzing different genetic mutations and disease-specific biomarkers.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients undergoing colorectal surgery for colorectal cancer.
Disqualifiers
Unwillingness to participate.
Trial population
Patients undergoing colorectal surgery due to colorectal cancer.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Overall survival
Patient overall survival at 5 years.
Disease-free survival
The time free of disease recurrence will be estimated in the whole cohort and according to colorectal cancer stages and molecular profiles.
Secondary outcomes
Molecular characteristics of colorectal adenocarcinoma.
At initial diagnosis, molecular tumor markers will be determined in the tissue samples.
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.